JENNIFER GUESS: Open Payments
NPI 1346717816 · BUCKEYE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 30 payments from 11 companies in 2025. Trend: 2023 $894 · 2024 $412 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $184 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $44 |
| Boston Scientific Corporation | 2 | $43 |
| Corcept Therapeutics | 2 | $36 |
| Abbott Laboratories | 2 | $36 |
| Lundbeck LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: BREZTRI, Ozempic, REXULTI, Veozah, WaveWriter Alpha Prime 16, Korlym, AIRSUPRA, Wegovy.
Industry payments across AZ — which companies pay providers there.
